McKesson (MCK) Misses Q2 EPS by 11c; Updates FY17 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
Go back to McKesson (MCK) Misses Q2 EPS by 11c; Updates FY17 EPS Outlook
October 28, 2016 10:29 AM EDT
Standpoint Research upgraded McKesson (NYSE: MCK) from Hold to Buy.
For an analyst ratings summary and ratings history on McKesson click here. For more ratings news on McKesson click here.
Shares of McKesson closed at $160.50 yesterday.
...
More
October 28, 2016 7:17 AM EDT
Deutsche Bank downgraded McKesson (NYSE: MCK) from Buy to Hold with a price target of $153.00 (from $196.00). Analyst George Hill expressed fears of a price war in drug wholesaling.
"MCK reported F2Q results below consensus, but it was the company's outlook and... More
October 28, 2016 7:08 AM EDT
Leerink Partners downgraded McKesson (NYSE: MCK) from Outperform to Market Perform with a price target of $160.00.
Analyst David Larsen commented, "MCK reported F2Q:17 adjusted EPS of $2.94 (-11% y/y) which was well below Leerink/Consensus of $3.10/$3.04. Management also reduced F2017 EPS... More
October 28, 2016 6:49 AM EDT
Baird downgraded McKesson (NYSE: MCK) from Outperform to Neutral with a price target of $164.00 (from $220.00).
For an analyst ratings summary and ratings history on McKesson click here. For more ratings news on McKesson click here.
Shares of McKesson closed at $160.50 yesterday.
...
More
